Using bacteriophages to reduce formation of catheter-associated biofilms by Staphylococcus epidermidis

Antimicrobial Agents and Chemotherapy

Volumn 50, Issue 4, 2006, Pages 1268-1275

  Curtin, John J ^a   Donlan, Rodney M ^a,b  

^a NATIONAL CENTER FOR EMERGING AND ZOONOTIC INFECTIOUS DISEASES   (United States)

^b NATL CENTER FOR INFECTIOUS DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIMICROBIAL THERAPY; ARTICLE; BACTERIAL COLONIZATION; BACTERIAL INFECTION; BACTERIOPHAGE; BIOFILM; CATHETER INFECTION; CENTRAL VENOUS CATHETER; COAGULASE NEGATIVE STAPHYLOCOCCUS; COLONY FORMING UNIT; HOSPITAL INFECTION; INCIDENCE; INDWELLING CATHETER; INFECTION PREVENTION; NONHUMAN; PRIORITY JOURNAL; STAPHYLOCOCCUS EPIDERMIDIS;

BIOFILMS; CATHETERS, INDWELLING; HUMANS; MICROSCOPY, ELECTRON, SCANNING; STAPHYLOCOCCUS EPIDERMIDIS; STAPHYLOCOCCUS PHAGES;

EID: 33645788842     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/AAC.50.4.1268-1275.2006     Document Type: Article

References (70)

1. Adams, M. 1959. Bacteriophages. Interscience Publishers, London, United Kingdom.
2. Barrow, P., M. Lovell, and A. Berchieri, Jr. 1998. Use of lytic bacteriophage for control of experimental Escherichia coli septicemia and meningitis in chickens and calves. Clin. Diagn. Lab. Immunol. 5:294-298.
3. Benoit, J. L., G. Carandang, M. Sitrin, and P. M. Arnow. 1995. Intraluminal antibiotic treatment of central venous catheter infections in patients receiving parenteral nutrition at home. Clin. Infect. Dis. 21:1286-1288.
4. Biswas, B., S. Adhya, P. Washart, B. Paul, A. N. Trostel, B. Powell, R. Carlton, and C. R. Merril. 2002. Bacteriophage therapy rescues mice bacteremic from a clinical isolate of vancomycin-resistant Enterococcus faecium. Infect. Immun. 70:204-210.
5. Capdevila, J. A., J. Gavalda, and A. Pahissa. 1996. Antibiotic-lock technique: usefulness and controversies. Antimicrobics Infect. Dis. Newsl. 15:9-13.
6. Carballo, J., C. M. Ferreiros, and M. T. Criado. 1991. Influence of blood proteins in the in vitro adhesion of Staphylococcus epidermidis to teflon, polycarbonate, polyethylene and bovine pericardium. Rev. Esp. Fisiol. 47: 201-208.
7. Ceri, H., M. E. Olson, C. Stremick, R. R. Read, D. Morck, and A. Buret. 1999. The Calgary Biofilm Device: new technology for rapid determination of antibiotic susceptibilities of bacterial biofilms. J. Clin. Microbiol. 37:1771-1776.
8. Christensen, G. D., L. M. Baddour, D. L. Hasty, J. H. Lowrance, and A. W. Simpson. 1989. Microbial and foreign body factors in the pathogenesis of medical device infections, p. 27-59. In A. L. Bisno and F. A. Waldvogel (ed.), Infections associated with indwelling medical devices. American Society for Microbiology, Washington, D.C.
9. Cislo, M., M. Dabrowski, B. Weber-Dabrowska, and A. Woyton. 1987. Bacteriophage treatment of suppurative skin infections. Arch. Immunol. Ther. Exp. 35:175-183.
10. Corbin, B. D., R. J. McLean, and G. M. Aron. 2001. Bacteriophage T4 multiplication in a glucose-limited Escherichia coli biofilm. Can. J. Microbiol. 47:680-684.
11. Costerton, J. W., Z. Lewandowski, D. E. Caldwell, D. R. Korber, and H. M. Lappin-Scott. 1995. Microbial biofilms. Annu. Rev. Microbiol. 49:711-745.
12. Costerton, J. W., P. S. Stewart, and E. P. Greenberg. 1999. Bacterial biofilms: a common cause of persistent infections. Science 284:1318-1322.
13. Curtin, J., M. Cormican, G. Fleming, J. Keelehan, and E. Colleran. 2003. Linezolid compared with eperezolid, vancomycin, and gentamicin in an in vitro model of antimicrobial lock therapy for Staphylococcus epidermidis central venous catheter-related biofilm infections. Antimicrob. Agents Chemother. 47:3145-3148.
14. Dean, B. A., R. E. Williams, F. Hall, and J. Corse. 1973. Phage typing of coagulase-negative staphylococci and micrococci. J. Hyg. 71:261-270.
15. D'Herelle, F. 1917. Sur un microbe invisible antagoniste des bacilles dysentériques. C. R. Acad. Sci. (Paris) 165:373-375.
16. DiTizio, V., G. W. Ferguson, M. W. Mittelman, A. E. Khoury, A. W. Bruce, and F. DiCosmo. 1998. A liposomal hydrogel for the prevention of bacterial adhesion to catheters. Biomaterials 19:1877-1884.
17. Donlan, R. M., and J. W. Costerton. 2002. Biofilms: survival mechanisms of clinically relevant microorganisms. Clin. Microbiol. Rev. 15:167-193.
18. Doolittle, M. M., J. J. Cooney, and D. E. Caldwell. 1995. Lytic infection of Escherichia coli biofilms by bacteriophage T4. Can. J. Microbiol. 41:12-18.
19. Doolittle, M. M., J. J. Cooney, and D. E. Caldwell. 1996. Tracing the interaction of bacteriophage with bacterial biofilms using fluorescent and chromogenic probes. J. Ind. Microbiol. 16:331-341.
20. Elliott, T. S., H. A. Moss, S. E. Tebbs, I. C. Wilson, R. S. Bonser, T. R. Graham, L. P. Burke, and M. H. Faroqui. 1997. Novel approach to investigate a source of microbial contamination of central venous catheters. Eur. J. Clin. Microbiol. Infect. Dis. 16:210-213.
21. Fang, G., T. F. Keys, L. O. Gentry, A. A. Harris, N. Rivera, K. Getz, P. C. Fuchs, M. Gustafson, E. S. Wong, A. Goetz et al. 1993. Prosthetic valve endocarditis resulting from nosocomial bacteremia. A prospective, multicenter study. Ann. Intern. Med. 119:560-567.
22. Flowers, R. H., III, K. J. Schwenzer, R. F. Kopel, M. J. Fisch, S. I. Tucker, and B. M. Farr. 1989. Efficacy of an attachable subcutaneous cuff for the prevention of intravascular catheter-related infection. A randomized, controlled trial. JAMA 261:878-883.
23. Fox, J. 2000. Phage treatments yield healthier tomato, pepper plants. ASM News 66:455-456.
24. Franson, T. R., N. K. Sheth, H. D. Rose, and P. G. Sohnle. 1984. Scanning electron microscopy of bacteria adherent to intravascular catheters. J. Clin. Microbiol. 20:500-505.
25. Galliani, S., M. Viot, A. Cremieux, and P. Van der Auwera. 1994. Early adhesion of bacteremic strains of Staphylococcus epidermidis to polystyrene: influence of hydrophobicity, slime production, plasma, albumin, fibrinogen, and fibronectin. J. Lab. Clin. Med. 123:685-692.
26. Gotz, F. 2002. Staphylococcus and biofilms. Mol. Microbiol. 43:1367-1378.
27. Gratia, A. 1936. Des relations numériques entre bactéries lysogènes et particules de bactériophagie. C. R. Soc. Biol. 122:812.
28. Hibma, A. M., S. A. Jassim, and M. W. Griffiths. 1997. Infection and removal of L-forms of Listeria monocytogenes with bred bacteriophage. Int. J. Food Microbiol. 34:197-207.
29. Hughes, K. A., I. W. Sutherland, J. Clark, and M. V. Jones. 1998. Bacteriophage and associated polysaccharide depolymerases-novel tools for study of bacterial biofilms. J. Appl. Microbiol. 85:583-590.
30. Hughes, K. A., I. W. Sutherland, and M. V. Jones. 1998. Biofilm susceptibility to bacteriophage attack: the role of phage-borne polysaccharide depolymerase. Microbiology 144:3039-3047.
31. Hume, E. B., J. Baveja, B. Muir, T. L. Schubert, N. Kumar, S. Kjelleberg, H. J. Griesser, H. Thissen, R. Read, L. A. Poole-Warren, K. Schindhelm, and M. D. Willcox. 2004. The control of Staphylococcus epidermidis biofilm formation and in vivo infection rates by covalently bound furanones. Biomaterials 25:5023-5030.
32. Jikia, D., N. Chkhaidze, E. Imedashvili, I. Mgaloblishvili, G. Tsitlanadze, R. Katsarava, J. G. Morris, Jr., and A. Sulakvelidze. 2005. The use of a novel biodegradable preparation capable of the sustained release of bacteriophages and ciprofloxacin, in the complex treatment of multidrug-resistant Staphylococcus aureus-infected local radiation injuries caused by exposure to Sr90. Clin. Exp. Dermatol. 30:23-26.
33. Kamal, G. D., D. Divishek, G. C. Kumar, B. R. Porter, D. J. Tatman, and J. R. Adams. 1998. Reduced intravascular catheter-related infection by routine use of antibiotic-bonded catheters in a surgical intensive care unit. Diagn. Microbiol. Infect. Dis. 30:145-152.
34. Kay, D. 1952. The effect of divalent metals on the multiplication of coli bacteriophage T 5st. Br. J. Exp. Pathol. 33:228-235.
35. Kluger, D., and D. Maki. 1999. The relative risk of intravascular device related bloodstream infections in adults, p. 514. 39th Intersci. Conf. Antimicrob. Agents Chemother.
36. Kristinsson, K. G. 1989. Adherence of staphylococci to intravascular catheters. J. Med. Microbiol. 28:249-257.
37. Maki, D. G. 1981. Nosocomial bacteremia. An epidemiologic overview. Am. J. Med. 70:719-732.
38. Maki, D. G., L. Cobb, J. K. Garman, J. M. Shapiro, M. Ringer, and R. B. Helgerson. 1988. An attachable silver-impregnated cuff for prevention of infection with central venous catheters: a prospective randomized multicenter trial. Am. J. Med. 85:307-314.
39. Maki, D. G., and L. A. Mermel. 1998. Infections due to infusion therapy, p. 689-724. In J. V. Bennett and P. S. Brachman (ed.), Hospital infections. Lippincott-Raven, Philadelphia, Pa.
40. Maki, D. G., M. Ringer, and C. J. Alvarado. 1991. Prospective randomised trial of povidone-iodine, alcohol, and chlorhexidine for prevention of infection associated with central venous and arterial catheters. Lancet 338:339-343.
41. Maki, D. G., and P. A. Tambyah. 2001. Engineering out the risk for infection with urinary catheters. Emerg. Infect. Dis. 7:342-347.
42. Markoishvili, K., G. Tsitlanadze, R. Katsarava, J. G. Morris, Jr., and A. Sulakvelidze. 2002. A novel sustained-release matrix based on biodegradable poly(ester amide)s and impregnated with bacteriophages and an antibiotic shows promise in management of infected venous stasis ulcers and other poorly healing wounds. Int. J. Dermatol. 41:453-458.
43. Mermel, L. A. 2000. Prevention of intravascular catheter-related infections. Ann. Intern. Med. 132:391-402.
44. Muller, E., S. Takeda, D. A. Goldmann, and G. B. Pier. 1991. Blood proteins do not promote adherence of coagulase-negative staphylococci to biomaterials. Infect. Immun. 59:3323-3326.
45. O'Grady, N. P., M. Alexander, E. P. Dellinger, J. L. Gerberding, S. O. Heard, D. G. Maki, H. Masur, R. D. McCormick, L. A. Mermel, M. L. Pearson, I.I. Raad, A. Randolph, and R. A. Weinstein. 2002. Guidelines for the prevention of intravascular catheter-related infections. Centers for Disease Control and Prevention. Morb. Mortal. Wkly. Rep. Recomm. Rep. 51:1-29.
46. Pascual, A., A. Fleer, N. A. Westerdaal, and J. Verhoef. 1986. Modulation of adherence of coagulase-negative staphylococci to Teflon catheters in vitro. Eur. J. Clin. Microbiol. 5:518-522.
47. Peters, G., R. Locci, and G. Pulverer. 1982. Adherence and growth of coagulase-negative staphylococci on surfaces of intravenous catheters. J. Infect. Dis. 146:479-482.
48. Raad, I., R. Darouiche, J. Dupuis, D. Abi-Said, A. Gabrielli, R. Hachem, M. Wall, R. Harris, J. Jones, A. Buzaid, C. Robertson, S. Shenaq, P. Curling, T. Burke, C. Ericsson, et al. 1997. Central venous catheters coated with minocycline and rifampin for the prevention of catheter-related colonization and bloodstream infections. A randomized, double-blind trial. Ann. Intern. Med. 127:267-274.
49. Raad, I. I., M. F. Sabbagh, K. H. Rand, and R. J. Sherertz. 1992. Quantitative tip culture methods and the diagnosis of central venous catheter-related infections. Diagn. Microbiol. Infect. Dis. 15:13-20.
50. Raad, I. I. 1998. Intravascular-catheter-related infections. Lancet 351:893-898.
51. Ramesh, V., J. Fralick, and R. Rolfe. 1999. Prevention of Clostridium difficile induced ileocecitis with bacteriophage. Anaerobe 5:69-78.
52. Richard, P., R. Le Floch, C. Chamoux, M. Pannier, E. Espaze, and H. Richet. 1994. Pseudomonas aeruginosa outbreak in a burn unit: role of antimicrobials in the emergence of multiply resistant strains. J. Infect. Dis. 170:377-383.
53. Rountree, P. M. 1955. The role of divalent cations in the multiplication of staphylococcal bacteriophages. J. Gen. Microbiol. 12:275-287.
54. Segura, M., F. Alvarez-Lerma, J. M. Tellado, J. Jimenez-Ferreres, L. Oms, J. Rello, T. Baro, R. Sanchez, A. Morera, D. Mariscal, J. Marrugat, and A. Sitges-Serra. 1996. A clinical trial on the prevention of catheter-related sepsis using a new hub model. Ann. Surg. 223:363-369.
55. Sillankorva, S., R. Oliveira, M. J. Vieira, I. W. Sutherland, and J. Azeredo. 2004. Bacteriophage Phi S1 infection of Pseudomonas fluorescens planktonic cells versus biofilms. Biofouling 20:133-138.
56. Slopek, S., B. Weber-Dabrowska, M. Dabrowski, and A. Kucharewicz- Krukowska. 1987. Results of bacteriophage treatment of suppurative bacterial infections in the years 1981-1986. Arch. Immunol. Ther. Exp. 35:569-583.
57. Smith, H. W., and M. B. Huggins. 1983. Effectiveness of phages in treating experimental Escherichia coli diarrhoea in calves, piglets and lambs. J. Gen. Microbiol. 129:2659-2675.
58. Smith, H. W., and M. B. Huggins. 1982. Successful treatment of experimental Escherichia coli infections in mice using phage: its general superiority over antibiotics. J. Gen. Microbiol. 128:307-318.
59. Smith, H. W., M. B. Huggins, and K. M. Shaw. 1987. The control of experimental Escherichia coli diarrhoea in calves by means of bacteriophages. J. Gen. Microbiol. 133:1111-1126.
60. Soothill, J. S. 1992. Treatment of experimental infections of mice with bacteriophages. J. Med. Microbiol. 37:258-261.
61. Terpenning, M. S., B. P. Buggy, and C. A. Kauffman. 1988. Hospital-acquired infective endocarditis. Arch. Intern. Med. 148:1601-1603.
62. Thomas, R. 1935. A bacteriophage in relation to Stewart's disease of corn. Phytopathology 25:371-372.
63. Twort, F. W. 1915. An investigation on the nature of ultramicroscopic viruses. Lancet 11:1241.
64. Veenstra, D. L., S. Saint, S. Sana, T. Lumley, and S. D. Sullivan. 1999. Efficacy of antiseptic-impregnated central venous catheters in preventing catheter-related bloodstream infection: a meta-analysis. JAMA 281:261-267.
65. von Eiff, C., C. Heilmann, and G. Peters. 1998. Staphylococcus epidermidis: why is it so successful? Clin. Microbiol. Infect. 4:207-300.
66. Walters, M. C., III, F. Roe, A. Bugnicourt, M. J. Franklin, and P. S. Stewart. 2003. Contributions of antibiotic penetration, oxygen limitation, and low metabolic activity to tolerance of Pseudomonas aeruginosa biofilms to ciprofloxacin and tobramycin. Antimicrob. Agents Chemother. 47:317-323.
67. Weber-Dabrowska, B., M. Mulczyk, and A. Gorski. 2000. Bacteriophage therapy of bacterial infections: an update of our institute's experience. Arch. Immunol. Ther. Exp. 48:547-551.
68. Weber-Dabrowska, B., M. Mulczyk, and A. Gorski. 2003. Bacteriophages as an efficient therapy for antibiotic-resistant septicemia in man. Transplant. Proc. 35:1385-1386.
69. Weber-Dabrowska, B., M. Mulczyk, and A. Gorski. 2001. Bacteriophage therapy for infections in cancer patients. Clin. Appl. Immunol. Rev. 1:131-134.
70. Wood, H. L., S. R. Holden, and R. Bayston. 2001. Susceptibility of Staphylococcus epidermidis biofilm in CSF shunts to bacteriophage attack. Eur. J. Pediatr. Surg. 11(Suppl. 1):S56-S57.